Literature DB >> 18262671

Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancer.

Giuseppe Sanguineti1, Michael Little, Eugene J Endres, Maria Pia Sormani, Brent C Parker.   

Abstract

PURPOSE: To compare three different contouring approaches of the bowel before and during whole pelvis IMRT of localized prostate cancer. MATERIALS: Nine patients were randomly selected among those treated for localized prostate cancer at UTMB from March 2004 to August 2006. On the planning CT, besides the usual organs at risk (OAR), for each patient we contoured the bowel according to three different definitions: each bowel segment ('BS'); 'BS+1', BS uniformly expanded by 1cm; intestinal cavity ('IC') or the 'container' of the bowel loops up to the pelvic/abdominal walls. For each patient we generated three rival plans each considering a different bowel definition, otherwise identical. Provided that the same target coverage and other OAR spare had been achieved, plans were compared for their ability to minimize bowel dose at planning. Furthermore, after co-registering 6 weekly CT to the initial planning CT for each patient, we investigated which of the three definitions would allow the best bowel protection also during treatment.
RESULTS: All definitions provided a very similar average bowel DVH at planning. During treatment BS allowed an average approximately 20 cc more of bowel to receive at least 45 Gy over BS+1 and IC (p=0.008 and 0.029, respectively); on the contrary bowel V45 between IC and BS+1 were not significantly different (p=0.65).
CONCLUSION: A definition that takes into account internal organ motion is warranted to maximize bowel protection during treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18262671     DOI: 10.1016/j.radonc.2008.01.015

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.

Authors:  Elizabeth H Baldini; Ross A Abrams; Walter Bosch; David Roberge; Rick L M Haas; Charles N Catton; Daniel J Indelicato; Jeffrey R Olsen; Curtiland Deville; Yen-Lin Chen; Steven E Finkelstein; Thomas F DeLaney; Dian Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-01       Impact factor: 7.038

2.  Dosimetric predictors of diarrhea during radiotherapy for prostate cancer.

Authors:  Giuseppe Sanguineti; Eugene J Endres; Maria Pia Sormani; Brent C Parker
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

3.  Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapy.

Authors:  Victor J Gonzalez; Craig R Hullett; Lindsay Burt; Prema Rassiah-Szegedi; Vikren Sarkar; Jonathan D Tward; Lisa J Hazard; Y Jessica Huang; Bill J Salter; David K Gaffney
Journal:  Adv Radiat Oncol       Date:  2017-01-24

4.  A Contouring Strategy and Reference Atlases for the Full Abdominopelvic Bowel Bag on Treatment Planning and Cone Beam Computed Tomography Images.

Authors:  Elizabeth Orton; Elsayed Ali; Keren Mayorov; Colin Brown; Nawaid Usmani; Shilo Lefresne; Michael Peacock; Kristopher Dennis
Journal:  Adv Radiat Oncol       Date:  2022-07-23

5.  A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer.

Authors:  Yeon Joo Kim; Jin-Hong Park; In-Ha Yun; Young Seok Kim
Journal:  Onco Targets Ther       Date:  2016-03-09       Impact factor: 4.147

6.  Optimization of re-irradiation using deformable registration: a case study.

Authors:  Raphaël Jumeau; Nicolas Péguret; Cédric Zulliger; Raphaël Moeckli; Jean Bourhis; Esat-Mahmut Ozsahin
Journal:  BJR Case Rep       Date:  2016-05-06

7.  Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer.

Authors:  Siyuan Li; Yanping Gong; Yongqiang Yang; Qi Guo; Jianjun Qian; Ye Tian
Journal:  Radiat Oncol       Date:  2020-09-01       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.